Pharmaceutical

FDA plans to expand unannounced inspections of foreign drug plants 

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.

May 8, 2025 - 06:00
FDA plans to expand unannounced inspections of foreign drug plants 
This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.
Read the original article

Tags:

Previous Article

ARS Pharma’s epinephrine nasal spray 1mg now available in US

Next Article

European biotechs must understand US culture while seeking funding

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Verve Therapeutics and Lilly partner to advance gene editing programme

Verve Therapeutics and Lilly partner to advance gene ed...

Jun 15, 2023

STAT+: $100 billion estimate for Ozempic-style weight loss drugs gets wary eye from analysts

STAT+: $100 billion estimate for Ozempic-style weight l...

Dec 5, 2023

STAT unveils a new look, and color. Our executive editor explains why

STAT unveils a new look, and color. Our executive edito...

Jun 28, 2023